3iwy
From Proteopedia
(Difference between revisions)
m (Protected "3iwy" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3iwy.png|left|200px]] | [[Image:3iwy.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3iwy", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3iwy| PDB=3iwy | SCENE= }} | {{STRUCTURE_3iwy| PDB=3iwy | SCENE= }} | ||
===Crystal structure of human MDM2 complexed with D-peptide (12 residues)=== | ===Crystal structure of human MDM2 complexed with D-peptide (12 residues)=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_20660730}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 20660730 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_20660730}} | {{ABSTRACT_PUBMED_20660730}} | ||
==About this Structure== | ==About this Structure== | ||
| - | [[3iwy]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IWY OCA]. | + | [[3iwy]] is a 4 chain structure of [[MDM2]]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IWY OCA]. |
| + | |||
| + | ==See Also== | ||
| + | *[[MDM2|MDM2]] | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:020660730</ref><references group="xtra"/> |
[[Category: Lu, W.]] | [[Category: Lu, W.]] | ||
[[Category: Pazgier, M.]] | [[Category: Pazgier, M.]] | ||
Revision as of 00:54, 26 July 2012
Contents |
Crystal structure of human MDM2 complexed with D-peptide (12 residues)
Template:ABSTRACT PUBMED 20660730
About this Structure
3iwy is a 4 chain structure of MDM2. Full crystallographic information is available from OCA.
See Also
Reference
- Liu M, Li C, Pazgier M, Li C, Mao Y, Lv Y, Gu B, Wei G, Yuan W, Zhan C, Lu WY, Lu W. D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proc Natl Acad Sci U S A. 2010 Jul 26. PMID:20660730
